Table of Contents
Journal of Blood Transfusion
Volume 2016, Article ID 9647675, 6 pages
http://dx.doi.org/10.1155/2016/9647675
Research Article

A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples

1Research and Development, Australian Red Cross Blood Service, Brisbane, QLD, Australia
2School of Medicine, The University of Queensland, Brisbane, QLD, Australia
3Medical Services, Australian Red Cross Blood Service, Perth, WA, Australia
4American Red Cross, Gaithersburg, MD, USA

Received 18 August 2016; Accepted 19 October 2016

Academic Editor: Sandra Ramirez-Arcos

Copyright © 2016 Ashish C. Shrestha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Meng, D. Anderson, V. Arankalle et al., “Hepeviridae,” in Virus Taxonomy, 9th Report of the ICTV, pp. 1021–1028, Elsevier Academic Press, London, UK, 2012. View at Google Scholar
  2. N. Kamar, R. Bendall, F. Legrand-Abravanel et al., “Hepatitis E,” The Lancet, vol. 379, no. 9835, pp. 2477–2488, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. B. Smith, M. A. Purdy, and P. Simmonds, “Genetic variability and the classification of hepatitis E virus,” Journal of Virology, vol. 87, no. 8, pp. 4161–4169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. H. C. Worm, W. H. M. van der Poel, and G. Brandstätter, “Hepatitis E: an overview,” Microbes and Infection, vol. 4, no. 6, pp. 657–666, 2002. View at Publisher · View at Google Scholar
  5. M. S. Balayan, A. G. Andjaparidze, S. S. Savinskaya et al., “Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route,” Intervirology, vol. 20, no. 1, pp. 23–31, 1983. View at Publisher · View at Google Scholar · View at Scopus
  6. G. R. Reyes, M. A. Purdy, J. P. Kim et al., “Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis,” Science, vol. 247, no. 4948, pp. 1335–1339, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Aggarwal, “Clinical presentation of hepatitis E,” Virus Research, vol. 161, no. 1, pp. 15–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. E. H. Teshale, D. J. Hu, and S. D. Holmberg, “The two faces of hepatitis E virus,” Clinical Infectious Diseases, vol. 51, no. 3, pp. 328–334, 2010. View at Publisher · View at Google Scholar
  9. A. Chauhan, J. B. Dilawari, Y. K. Chawla, S. Jameel, U. Kaur, and N. K. Ganguly, “Hepatitis E virus transmission to a volunteer,” The Lancet, vol. 341, no. 8838, pp. 149–150, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. I. K. Mushahwar, “Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention,” Journal of Medical Virology, vol. 80, no. 4, pp. 646–658, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. C. Shrestha, H. M. Faddy, R. L. P. Flower, C. R. Seed, and A. J. Keller, “Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history?” Pathology, vol. 47, no. 2, pp. 97–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Kamar, J. Selves, J.-M. Mansuy et al., “Hepatitis E virus and chronic hepatitis in organ-transplant recipients,” The New England Journal of Medicine, vol. 358, no. 8, pp. 811–817, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. R. Dalton, R. P. Bendall, F. E. Keane, R. S. Tedder, and S. Ijaz, “Persistent carriage of hepatitis E virus in patients with HIV infection,” The New England Journal of Medicine, vol. 361, no. 10, pp. 1025–1027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Le Coutre, H. Meisel, J. Hofmann et al., “Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation,” Gut, vol. 58, no. 5, pp. 699–702, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. U. Navaneethan, “Seroprevalence of hepatitis E infection in pregnancy—more questions than answers,” Indian Journal of Medical Research, vol. 130, no. 6, pp. 677–679, 2009. View at Google Scholar · View at Scopus
  16. M. S. Khuroo, M. R. Teli, S. Skidmore, M. A. Sofi, and M. I. Khuroo, “Incidence and severity of viral hepatitis in pregnancy,” The American Journal of Medicine, vol. 70, no. 2, pp. 252–255, 1981. View at Publisher · View at Google Scholar · View at Scopus
  17. P. E. Hewitt, S. Ijaz, S. R. Brailsford et al., “Hepatitis e virus in blood components: a prevalence and transmission study in southeast England,” The Lancet, vol. 384, no. 9956, pp. 1766–1773, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Mansuy, K. Saune, H. Rech et al., “Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011,” Euro Surveillance, vol. 20, no. 19, pp. 27–34, 2015. View at Google Scholar · View at Scopus
  19. F. Ren, C. Zhao, L. Wang et al., “Hepatitis E virus seroprevalence and molecular study among blood donors in China,” Transfusion, vol. 54, no. 3, pp. 910–917, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. C. Shrestha, C. R. Seed, R. L. P. Flower et al., “Hepatitis E virus and implications for blood supply safety, Australia,” Emerging Infectious Diseases, vol. 20, no. 11, pp. 1940–1942, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-M. Mansuy, R. Bendall, F. Legrand-Abravanel et al., “Hepatitis E virus antibodies in blood donors, France,” Emerging Infectious Diseases, vol. 17, no. 12, pp. 2309–2312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. M. Ghabrah, S. Tsarev, P. O. Yarbough, S. U. Emerson, G. T. Strickland, and R. H. Purcell, “Comparison of tests for antibody to hepatitis E virus,” Journal of Medical Virology, vol. 55, no. 2, pp. 134–137, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Bendall, V. Ellis, S. Ijaz, P. Thurairajah, and H. R. Dalton, “Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response,” Journal of Medical Virology, vol. 80, no. 1, pp. 95–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sultan Khuroo, S. Kamili, M. Yousuf Dar, R. Moecklii, and S. Jameel, “Hepatitis E and long-term antibody status,” The Lancet, vol. 341, no. 8856, p. 1355, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. H. R. Dalton, R. Bendall, S. Ijaz, and M. Banks, “Hepatitis E: an emerging infection in developed countries,” The Lancet Infectious Diseases, vol. 8, no. 11, pp. 698–709, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Schnegg, P. Bürgisser, C. André et al., “An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European Population,” PLoS ONE, vol. 8, no. 5, article e62980, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Bendall, V. Ellis, S. Ijaz, R. Ali, and H. Dalton, “A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries,” Journal of Medical Virology, vol. 82, no. 5, pp. 799–805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. B. H. M. Meldal, F. Sarkodie, S. Owusu-Ofori, and J.-P. Allain, “Hepatitis E virus infection in Ghanaian blood donors—the importance of immunoassay selection and confirmation,” Vox Sanguinis, vol. 104, no. 1, pp. 30–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. H. K. Park, S. Jeong, J. Kim et al., “Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays,” BMC Infectious Diseases, vol. 12, no. 1, article 142, 2012. View at Publisher · View at Google Scholar
  30. J. J. Wenzel, J. Preiss, M. Schemmerer, B. Huber, and W. Jilg, “Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis e seroprevalence estimates,” Journal of Infectious Diseases, vol. 207, no. 3, pp. 497–500, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Drobeniuc, J. Meng, G. Reuter et al., “Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances,” Clinical Infectious Diseases, vol. 51, no. 3, pp. e24–e27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. Wantai HEV-IgG ELISA, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., http://www.ystwt.cn/IFU/HEV/HEV-IgG_CE.pdf
  33. Q. Yan, H. Du, Y. Wang et al., “Comparison of two diagnostic reagents to detect anti-hepatitis E virus IgG antibodies,” Chinese Journal of Zoonoses, vol. 24, pp. 1087–1089, 2008. View at Google Scholar
  34. Wantai HEV-IgM ELISA, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd, http://www.ystwt.cn/IFU/HEV/HEV-IgM_CE.pdf
  35. MP Biomedicals, USA, http://www.mpbio.com/featured.php?fid=25&country=13
  36. M. K. Yong, E. K. Paige, D. Anderson, and J. F. Hoy, “Hepatitis E in Australian HIV-infected patients: an under-recognised pathogen?” Sexual Health, vol. 11, no. 4, pp. 375–378, 2014. View at Google Scholar
  37. F. Legrand-Abravanel, I. Thevenet, J. M. Mansuy et al., “Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections,” Clinical and Vaccine Immunology, vol. 16, no. 5, pp. 772–774, 2009. View at Publisher · View at Google Scholar